Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system

Overview of attention for article published in Child's Nervous System, September 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 3,223)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 6 news outlets
twitter: 27 X users

facebook: 12 Facebook pages

Readers on

mendeley: 48 Mendeley

Summary News X Facebook

So far, Altmetric has seen 8 news stories from 6 outlets.

PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

Fat Pitch Financials: Stock Quote, 04 Jan 2017

Markets Stocks Funds Sectors Tools Overview Market News Market Videos Currencies International Treasury

PharmaCyte Biotech's Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

Benzinga, 27 Dec 2016

LAGUNA HILLS, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

NASDAQ, 27 Dec 2016

LAGUNA HILLS, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

Yahoo! Finance USA, 27 Dec 2016

LAGUNA HILLS, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.